Literature DB >> 9552019

Standards for the optimal management of COPD: a summary.

B R Celli1.   

Abstract

Tobacco smoking is the main cause of COPD, and encouragement and support in smoking cessation is the best way to help the patient with COPD. The three major goals of COPD management are to lessen airflow limitation, to prevent and treat secondary medical complications, and to decrease respiratory symptoms and improve quality of life. Outpatient pharmacotherapy should be organized in a stepwise manner according the severity of disease, the aims being to induce bronchodilation, reduce inflammation, and facilitate expectoration, although the role of anti-inflammatory and mucolytic treatment of COPD has not been clearly established. Patients whose conditions are not well controlled with optimal pharmacotherapy are candidates for enrollment in a pulmonary rehabilitation program. Correction or prevention of hypoxemia is a priority, and long-term oxygen therapy supplementation prolongs survival in hypoxemic patients. With only limited data on criteria for hospital admission and the objectives of hospitalization, the published standards on the management of COPD include an expert consensus statement on these aspects of hospital care. Surgery, special considerations such as sleep, nutrition, and air travel, and ethical issues are discussed.

Entities:  

Mesh:

Year:  1998        PMID: 9552019     DOI: 10.1378/chest.113.4_supplement.283s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  The role of exercise prescription in chronic disease.

Authors:  G E Moore
Journal:  Br J Sports Med       Date:  2004-02       Impact factor: 13.800

2.  Application of appropriateness criteria for hospitalization in COPD exacerbation.

Authors:  Susana Garcia-Gutierrez; José M Quintana; Irantzu Barrio; Marisa Bare; Nerea Fernandez; Silvia Vidal; Nerea Gonzalez; Iratxe Lafuente; Edurne Arteta; Cristóbal Esteban; Esther Pulido
Journal:  Intern Emerg Med       Date:  2013-03-19       Impact factor: 3.397

3.  Longitudinal changes in health status using the chronic respiratory disease questionnaire and pulmonary function in patients with stable chronic obstructive pulmonary disease.

Authors:  T Oga; K Nishimura; M Tsukino; T Hajiro; S Sato; A Ikeda; C Hamadas; M Mishima
Journal:  Qual Life Res       Date:  2004-08       Impact factor: 4.147

4.  Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease.

Authors:  Shalini Naik; Khalid M Kamal; Patricia A Keys; Thomas J Mattei
Journal:  Clinicoecon Outcomes Res       Date:  2010-03-09

5. 

Authors:  S Sánchez Fraga; F García Río; J Villamor León
Journal:  Medicine (Madr)       Date:  2013-04-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.